Description
LHC-165 is a benzonaphthyridine TLR7 agonist.
Product Unit Size | Cost | Quantity | Stock |
---|
LHC-165 is a benzonaphthyridine TLR7 agonist.
Cas No. | 1258595-14-0 |
---|---|
Purity | ≥99% |
Formula | C29H32F2N3O7P |
Formula Wt. | 603.56 |
IUPAC Name | 3-[5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]benzo[f][1,7]naphthyridin-8-yl]propanoic acid |
Synonym | LHC165 |
Appearance | Pale yellow powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Zawit M, Swami U, Awada H, et al. Current status of intralesional agents in treatment of malignant melanoma. Ann Transl Med. 2021 Jun;9(12):1038. PMID: 34277838
Endogenous amino acid sugar involved in cartila...
Mixture of taxanes.
Nitrogen mustard and estradiol derivative; micr...
DAT inhibitor.
NSAID; COX-1/2 and PDE inhibitor.
Atazanavir metabolite; HIV protease inhibitor.<...
STING inhibitor
Fluoroquinolone; bacterial DNA gyrase inhibitor...
ACE inhibitor.
Cdc42 inhibitor.
mAChR antaonist.
Polyphenol found in Camilla sinensis; HIV integ...
PARP inhibitor; potential Pim1 inhibitor.
Flavonoid found in various plant sources; GABA-...
β-lactam; penicillin binding protein inhibitor...
Synthetic fluorinated thiamphenicol analog; pro...
inhibits inflammatory signaling
Endogenous steroid hormone, estriol precursor; ...
Building block